The DOI matches its Crossref record; 13 of the 14 references it cites were found in a registry or an index, and 1 are not checked yet.
Impact of COVID-19 on clinical trials and clinical research: A systematic review
Open accessAbstract
Background: The World Health Organization has reported more than 31,186,000 confirmed cases of coronavirus disease-19 (COVID-19), including 962,343 deaths, worldwide as on September 21, 2020. The current COVID-19 pandemic is affecting clinical research activities in most parts of the world. The focus on developing a vaccine for SARS-CoV-2 and the treatment of COVID-19 is, in fact, disrupting many upcoming and/or ongoing clinical trials on other diseases around the globe. On March 18, 2020, the United States Food and Drug Administration (FDA) issued an updated guideline for the conduct of clinical trials during the current health emergency situation. The potential challenges, such as social distancing and quarantines, result in study participants’ inaccessibility and trial personnel for in-person scheduled study visits and/or follow-up. Due to the sudden onset and wide-spread impact of COVID-19, its influence on the management of clinical trials and research necessitates urgent attention. Therefore, our systematic review of the literature aims to assess the impact of the COVID-19 pandemic on the conduction of clinical trials and research. The search for the relevant articles for review included the keywords "COVID-19” AND "clinical trial" in PubMed, MEDLINE, Embase, Google scholar and Google electronic databases. Key findings include: delaying subject enrollment and operational gaps in most ongoing clinical trials, which in turn has a negative impact on trial programmes and data integrity. Globally, most sites conducting clinical trials other than COVID-19 are experiencing a delay in timelines and a complete halt of operations in lieu of this pandemic, thus affecting clinical research outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Finally, our study was disrupted by the COVID-19 pandemic, which was the case for clinical research in general (Padala et al., 2020; Sathian et al., 2020).”
From Feasibility, Acceptability and Preliminary Efficacy of Dialectical Behavior Therapy for Autistic Adults without Intellectual Disability: A Mixed Methods Study (2022) · cites this paper as Sathian et al., 2020
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Home visits: a strategy to improve newborn survival - Authors' reply
(2008) · Americanae (AECID Library) · doi:10.1016/s0140 · Cited by 22,524
Wang, G., Ma, R., Qiao, G., Wada, K., Aizawa, Y., & Satoh, T. (2015) · Integrative Medicine International · doi:10.1159/000368408 · Cited by 18,762
Chapter 7: Systematic reviews of etiology and risk
Moola, S., Munn, Z., Tufanaru, C., Aromataris, E., Sears, K., Sfetic, R., Currie, M., Lisy, K., Qureshi, R., Mattis, P., et al. (2019) · JBI Reviewer's Manual · doi:10.46658/jbirm-17-06 · Cited by 2,114
Telehealth for global emergencies: Implications for coronavirus disease 2019 (COVID-19)
Smith, A. C., Thomas, E., Snoswell, C. L., Haydon, H., Mehrotra, A., Clemensen, J., & Caffery, L. J. (2020) · Journal of Telemedicine and Telecare · doi:10.1177/1357633x20916567 · Cited by 1,828
A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment
Munster, V. J., Koopmans, M., van Doremalen, N., van Riel, D. A. J., & de Wit, E. (2020) · New England Journal of Medicine · doi:10.1056/nejmp2000929 · Cited by 1,418
COVID-19: what is next for public health?
Heymann, D. L., & Shindo, N. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30374-3 · Cited by 1,146
Waterhouse, D. M., Harvey, R. D., Hurley, P., Levit, L. A., Kim, E. S., Klepin, H. D., Mileham, K. F., Nowakowski, G., Schenkel, C., Davis, C., et al. (2020) · JCO Oncology Practice · doi:10.1200/op.20.00275 · Cited by 199
Preserving Clinical Trial Integrity During the Coronavirus Pandemic
McDermott, M. M., & Newman, A. B. (2020) · JAMA · doi:10.1001/jama.2020.4689 · Cited by 193
COVID-19 and readjusting clinical trials
van Dorn, A. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31787-6 · Cited by 186
Cited by
Sorted by citations
Items 201–242 of 242
Mathiesen, A. S., Zoffmann, V., Lindschou, J., Jakobsen, J. C., Gluud, C. N., Olsen, M. H., Rasmussen, B., Marqvorsen, E. H. S., & Rothmann, M. J. (2024) · Research Square · doi:10.21203/rs.3.rs-3669654/v1
Khokholov, A., Eleskina, A., & Belchik, L. (2024) · Медицинская этика · doi:10.24075/medet.2024.008
Digitale Technik für ambulante Pflege und Therapie III
Weber, K., Haug, S., Lauer, N., Mohr, C., Pfingsten, A., Raptis, G., & Bahr, G. (2024) · Regensburger Beiträge zur Digitalisierung des Gesundheitswesens · doi:10.14361/9783839467282
Spesolimab use in generalised pustular psoriasis flares
Osborne, S., Thacker, S., Kam, O., Wescott, R., & Wu, J. J. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01558-7
Ebor, M. T., Viducich, I. M., & Sutton, M. Y. (2024) · Journal of Social Work and Social Welfare Policy · doi:10.33790/jswwp1100122
Addressing unmet social needs of children with obesity: a pilot randomized controlled trial
Wahi, G., Marjerrison, S., Gill, S., Krasevich, K., Morrison, K. M., & Thabane, L. (2024) · Pilot and Feasibility Studies · doi:10.1186/s40814-024-01570-9 · Cited by 1
Pasteur, I. P. (2024) · Endokrynologia · doi:10.31793/1680-1466.2024.29-2.183
Mapping a Decade of Research: Bibliometric Analysis of Iron Overload in Chronic Kidney Disease
Nashwan, A. J., Kunjavara, J., Al-Mashdali, A. F., & Yassin, M. A. (2024) · Cureus · doi:10.7759/cureus.75766
Stabile, S., Testoni, S., Franchina, V., Betti, M., Mannozzi, F., Ferrari, A., Federici, I., Doungue, L., & Cagnazzo, C. (2025) · Reviews on Recent Clinical Trials · doi:10.2174/0115748871363256250117172437
Comment on “Impact of the COVID-19 pandemic on research publications in emergency medicine”
Gurnani, B., & Kaur, K. (2025) · World Journal of Emergency Medicine · doi:10.5847/wjem.j.1920-8642.2025.026
Arader, L., Miller, D., Perrin, A., Vicari, F., Friel, C. P., Vrany, E. A., Goodwin, A. M., & Butler, M. J. (2025) · Journal of Medical Internet Research · doi:10.2196/54629
Developing a public-facing tool to monitor inclusion of special populations in clinical research
Lam, W. K. K., Goodrich, J., Sullivan, S., Bentley‐Edwards, K. L., Koeberl, D. D., & Noonan, D. (2025) · Journal of Clinical and Translational Science · doi:10.1017/cts.2025.48
Effects and mechanisms of esketamine on depression by targeting gut microbiota: A narrative review
Liu, J., & Zhou, C. (2025) · New discovery. · doi:10.61958/ndfs6517
Layton, T., Eramudugolla, R., Sinclair, C., Gad, I., Mortby, M. E., & Anstey, K. J. (2025) · Archives of Public Health · doi:10.1186/s13690-025-01646-9
Aldarraji, H. A., Alshalkhaty, A., Asaad, O. M., Tahmaz, G. A. A., saleh, R. A. A., & Hussein, A. (2025) · Cureus · doi:10.7759/cureus.86850
Mahdi, S., Chilcott, J., & Buckland, N. J. (2025) · BMC Public Health · doi:10.1186/s12889-025-23400-0
Evans, I., Duplancic, C., Kidd, T. J., Ballard, E. L., Thomson, R. M., Wainwright, C. E., & Bell, S. C. (2025) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2025.07.002
Clinical trials in otology and neurotology: state of the science
Moore, L. S., Sagi, V., & Stanković, K. M. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1598789
Sustainability of Clinical Trials after the Historical Experience of COVID-19
Ardelean, M., Mihaicuta, S. D., Coroian, A., Samfirescu, M., & Dobre, A. (2025) · Proceedings of the ... International Conference on Business Excellence · doi:10.2478/picbe-2025-0385
Newman, C., Dunne, F., Alvarez‐Iglesias, A., Browne, M. B., Byrnes, M. C., Devane, D., Gillespie, P., Ryan, C., Scairati, R., Wallace, S., et al. (2025) · HRB Open Research · doi:10.12688/hrbopenres.14233.1
COVID-19 pandemic and enrollment of critically Ill children in randomized clinical trials
Kandil, S. B., Panisello‐Manterola, D., Chegondi, M., Allen, C. J., Cholette, J. M., Kong, M. Y. F., Pinto, M. G., Schreiber, H., Glau, C. L., & Faustino, E. V. S. (2025) · Frontiers in Pediatrics · doi:10.3389/fped.2025.1704390
Additional file 1 of Barriers to symptom management care pathway implementation in pediatric Cancer
Dupuis, L. L., Grimes, A., Vettese, E., Klesges, L. M., & Sung, L. (2021) · Figshare · doi:10.6084/m9.figshare.16779526
FitzGerald, C., Vaughan, A., Barry, L. A., Corey, G., Leahy, F. C., Egan, S., Conway, E., O’Connor, M., & Galvin, R. (2023) · Figshare · doi:10.6084/m9.figshare.24225220
Eriksson, A. F., Orwelius, L., Årestedt, K., Chew, M. S., & Wenemark, M. (2026) · Journal of Patient-Reported Outcomes · doi:10.1186/s41687-026-00993-7
Campbell, E., Cassells, A. N., Lin, T. J., Lainez, J. C., Smaldone, A. M., Desai, P., Jia, H., Hripcsak, G. M., Tobin, J. N., & Mamykina, L. (2026) · Contemporary Clinical Trials · doi:10.1016/j.cct.2026.108250
Sivel, I., Rief, W., & Weise, C. (2026) · Research Square · doi:10.21203/rs.3.rs-8768371/v1
Sajatovic, M., Still, C. H., Lute, B., Krehel-Montgomery, J., Surdam, J., Fuentes‐Casiano, E., Whitlow, J., Conroy, C. M., Broadnax, M., Moore, S., et al. (2026) · American Journal of Men s Health · doi:10.1177/15579883261424111
Chendake, M. B., Shelke, A. B., & Mohite, V. R. (2026) · Frontiers of Nursing · doi:10.2478/fon-2026-0014
Winslow, B. D., Mills, E. H. L., Farrag, S., Wyatt, E., Miro, R. M., Ramrattan, A., Courtade, A. M., & Highsmith, M. J. (2026) · Technology & Innovation · doi:10.1080/19498241.2026.2645732
Gherraby-Bidaut, W. (2021) · doi:10.70675/50d469b1za3e5z4f8ez872bz72af92cf6ca0
Daniel, M. N., Buchholz, S. W., Schoeny, M. E., Kitsiou, S., Halloway, S., Johnson, T., Vispute, S., & Wilbur, J. (2026) · Annals of Behavioral Medicine · doi:10.1093/abm/kaag010
The challenge of recruitment in clinical trials in Canada: an analysis of trial registry data
Tam, A. C. T., Smith, J., Harrison, M. J., Murthy, S., & Bansback, N. J. (2026) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2026.112334
Artificial Intelligence a New Challenge for the Sustainability of Clinical Trial Centers
Ardelean, M., Ivaşcu, L., Ardelean, C. L., Mihaicuta, S. D., Lighezan, D.-F., & Galateanu, V. (2026) · Intelligent systems reference library · doi:10.1007/978-3-032-24395-9_13
Carlisle, B. G., Hutchinson, N., & Moyer, H. (2026) · medRxiv · doi:10.64898/2026.05.20.26353581
Phase III Trials in India: A Comprehensive Analysis of the Clinical Trials Registry-India
Sahoo, A., Meher, B. R., Jena, M., & Padhy, B. M. (2026) · Cureus · doi:10.7759/cureus.110645
Annevelink, R., Don, S., Nijs, J., Beckwée, D., Ickmans, K., Cools, W., & Voogt, L. P. (2026) · Pain · doi:10.1097/j.pain.0000000000004047
Sivel, I., Rief, W., & Weise, C. (2026) · Clinical Psychology & Psychotherapy · doi:10.1002/cpp.70311
Chen, J. C., Skolarus, T. A., Furgal, A. K. C., Rankin, A., Wallner, L. P., Borza, T., Hawley, S. T., & Radhakrishnan, A. (2026) · BMC Cancer · doi:10.1186/s12885-026-16625-8
Marconato, M., Jäger, S., Tegeler, C. M., Hackenbruch, C., Salih, H. R., Walz, J. S., Federmann, B., & Heitmann, J. S. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1844041
Hyde, C., Kasari, C. L., McDonald, N. M., Vobecky, M., Pizzano, M., Panganiban, J. L., Gharapetian, B., Tran, E. Y., Nelson, C. A., Thiele, E. A., et al. (2026) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.70384
Lee, S., Yu, K., & Huh, K. Y. (2026) · Translational and Clinical Pharmacology · doi:10.12793/tcp.2026.34.e11
Tripathi, R. K., Kapadia, U. R., Kajrolkar, A. V., & Parmar, U. I. (2026) · Cureus · doi:10.7759/cureus.117881
Metadata
- Authors
- Sathian, B., Asim, M., Banerjee, I., Pizarro, A. B., Roy, B., Van Teijlingen, E. R., Nascimento, I. J. B. D., & Alhamad, H. K.
- Affiliations
- Hamad Medical Corporation (QA)
- Hamad General Hospital (QA)
- Pontificia Universidad Javeriana (CO)
- Quest International University Perak (MY)
- Universidade Federal de Minas Gerais (BR)
- Corresponding author
- Sathian, Brijesh
- ORCID
- Venue
- Nepal Journal of Epidemiology
- Publisher
- Nepal Journals Online (JOL)
- Published
- 2020-09-30
- Volume
- 10
- Issue
- 3
- Pages
- 878-887
- ISSN
- 2091-0800 (ISSN-L)
- PMC
- PMC7538012
- OpenAlex
- W3091584968
- Cited by
- 242
- References
- 13
- Citations by year
- 2026: 20 · 2025: 39 · 2024: 44 · 2023: 49 · 2022: 53 · 2021: 35 · 2020: 1
- FWCI
- 3.70
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Nepal Journal of Epidemiology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Bournemouth University Research Online (Bournemouth University) (acceptedVersion)
- Topics
- Health Sciences › Medicine › Oncology › COVID-19 and healthcare impacts
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ethics in Clinical Research
- Keywords
- COVID-19 pandemic, clinical trials, social distancing, quarantine, data integrity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
